HBV mutation literature information.


  Analysis of HBV basal core promoter/precore gene variability in patients with HBV drug resistance and HIV co-infection in Northwest Ethiopia.
 PMID: 29408943       2018       PloS one
Table: T148P


  HIV therapy with unknown HBV status is responsible for higher rate of HBV genome variability in Ethiopia.
 PMID: 27354181       2017       Antiviral therapy
Abstract: In particular, the 'a' determinant surface gene mutations (sT125S, sA128V, sQ129H/R, sT131I, sC137S, sT143M, sD144D/E, sG145R, sT148P) and the majority of clustered/multiple as well as drug selected immune escape HBsAg mutations were more prevalent



Browser Board

 Co-occurred Entities




   Filtrator